首页> 外文期刊>Breastfeeding medicine: the official journal of the Academy of Breastfeeding Medicine >Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants
【24h】

Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants

机译:坏死性小肠结肠炎的成本和仅以人乳为基础的产品在喂养极早产婴儿方面的成本效益

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: This study evaluated the cost-effectiveness of a 100% human milk-based diet composed of mother's milk fortified with a donor human milk-based human milk fortifier (HMF) versus mother's milk fortified with bovine milk-based HMF to initiate enteral nutrition among extremely premature infants in the neonatal intensive care unit (NICU). Methods: A net expected costs calculator was developed to compare the total NICU costs among extremely premature infants who were fed either a bovine milk-based HMF-fortified diet or a 100% human milk-based diet, based on the previously observed risks of overall necrotizing enterocolitis (NEC) and surgical NEC in a randomized controlled study that compared outcomes of these two feeding strategies among 207 very low birth weight infants. The average NICU costs for an extremely premature infant without NEC and the incremental costs due to medical and surgical NEC were derived from a separate analysis of hospital discharges in the state of California in 2007. The sensitivity of cost-effectiveness results to the risks and costs of NEC and to prices of milk supplements was studied. Results: The adjusted incremental costs of medical NEC and surgical NEC over and above the average costs incurred for extremely premature infants without NEC, in 2011 US$, were $74,004 (95% confidence interval, $47,051- $100,957) and $198,040 (95% confidence interval, $159,261-$236,819) per infant, respectively. Extremely premature infants fed with 100% human-milk based products had lower expected NICU length of stay and total expected costs of hospitalization, resulting in net direct savings of 3.9 NICU days and $8,167.17 (95% confidence interval, $4,405-$11,930) per extremely premature infant (p<0.0001). Costs savings from the donor HMF strategy were sensitive to price and quantity of donor HMF, percentage reduction in risk of overall NEC and surgical NEC achieved, and incremental costs of surgical NEC. Conclusions: Compared with feeding extremely premature infants with mother's milk fortified with bovine milk-based supplements, a 100% human milk-based diet that includes mother's milk fortified with donor human milk-based HMF may result in potential net savings on medical care resources by preventing NEC.
机译:目的:本研究评估了由以供体人乳为基础的人乳强化剂(HMF)强化的母乳相对于以牛乳为基础的HMF强化肠内营养的100%以母乳为基础的饮食的成本效益新生儿重症监护病房(NICU)的极早产婴儿中。方法:根据先前观察到的总体风险,开发了一个净预期成本计算器,用于比较以牛乳为基础的HMF强化饮食或100%母乳为基础喂养的极早产婴儿的总NICU成本。一项随机对照研究比较了207例极低出生体重婴儿的两种坏死性小肠结肠炎(NEC)和手术NEC的效果。没有NEC的极早产婴儿的平均NICU费用以及由于医学和外科NEC导致的增量费用来自2007年加利福尼亚州对医院出院的单独分析。成本效益对风险和成本的敏感性NEC的价格和牛奶补充剂的价格进行了研究。结果:2011年,医疗NEC和外科NEC的调整后增量成本超出了无NEC的极早产婴儿的平均成本,分别为74,004美元(95%置信区间,47,051- 100,957美元)和198,040美元(95%置信区间) (分别为每名婴儿159,261美元至236,819美元)。喂食100%以人乳为基础的产品的极早产婴儿的预期重症监护病房住院天数和预期住院总费用较低,因此,每例极重早产儿的净直接节省为3.9个重症监护病房天数和$ 8,167.17(95%置信区间,$ 4,405- $ 11,930)婴儿(p <0.0001)。捐赠者HMF策略节省的成本对捐赠者HMF的价格和数量,整体NEC和手术NEC风险降低的百分比以及手术NEC的增量成本敏感。结论:与用胎牛乳补充剂强化母乳喂养极早产婴儿相比,包括以供体人乳基HMF强化母乳的100%母乳基饮食可通过以下方式节省医疗资源净额:预防NEC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号